[Informe de investigación] Se espera que el mercado de detección del cáncer de mama alcance los 6.209,25 millones de dólares en 2027, desde los 4.638,63 millones de dólares de 2019; se estima que crecerá a una tasa compuesta anual del 4,8 % entre 2020 y 2027.
El cáncer de mama es el tipo de cáncer más común y extendido entre las mujeres; se desarrolla en los tejidos mamarios, generalmente en los conductos (tubos que llevan la leche al pezón) y los lóbulos (glándulas que producen leche). También puede ocurrir en el tejido adiposo o el tejido conectivo fibroso dentro de los senos. El diagnóstico temprano del cáncer de mama es importante ya que puede evitar que la afección se vuelva crítica y garantizar un tratamiento curable exitoso. Los métodos de detección para el diagnóstico del cáncer de mama incluyen mamografía, resonancia magnética (MRI), ultrasonido y otros. El objetivo principal de la detección es detectar la enfermedad en su etapa más temprana y tratable. Los procedimientos de detección identifican los primeros signos de cáncer, incluso antes de que los síntomas comiencen a aparecer.
Mercados regionales lucrativos de detección de cáncer de mamaPerspectivas del mercado
Prevalencia creciente del cáncer de mama a nivel mundial
El cáncer de mama se encuentra entre las principales causas de muerte en el mundo y está afectando profundamente la calidad de vida. Por tanto, actúa como una carga para la sociedad si no se diagnostica y trata a tiempo. Según las estimaciones de la Sociedad Estadounidense del Cáncer, el cáncer de mama es el tipo de cáncer más común en los EE. UU., ya que causó morbilidad en ~234 087 personas y provocó 41 904 muertes en 2018. Además, se esperan ~276 480 nuevos casos en el país en 2020. Según el informe Globocan 2019, en Alemania, el número total de casos de cáncer de mama en 2018 fue de 71,888, y alrededor de la enfermedad provocó ~19,376 muertes en ese año. Además, según el informe de Globocan, en 2018 hubo ~367.900 nuevos casos de cáncer de mama y 97.972 muertes por el mismo motivo en China. En India, ONG, agencias gubernamentales y organizaciones benéficas están haciendo hincapié en la concientización sobre el cáncer de mama entre la población para promover la detección temprana, proporcionar un módulo de tratamiento integral y ampliar el apoyo para el manejo del cáncer de mama. Este tipo de iniciativas son resultado de la creciente prevalencia de este tipo de cáncer en el país. Según la estimación del informe Globocan, en 2018, India informó ~162,468 nuevos casos de cáncer de mama y 87,090 muertes debido al mismo. Esta creciente prevalencia del cáncer de mama en diferentes regiones del mundo está aumentando la demanda global de dispositivos de detección para el mismo.
Basado en el tipo de prueba Información sobre el mercado
El mercado de detección del cáncer de mama, por tipo de producto, se segmenta en pruebas de marcadores sanguíneos, pruebas de imagen, pruebas genéticas y pruebas de inmunohistoquímica. El segmento de pruebas de imágenes tuvo la mayor participación del mercado en 2019, y también se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.
Global Breast Mercado de detección de cáncer, por tipo de producto: 2018 y 2027
Información basada en el usuario final
Según el usuario final, el seno El mercado de detección del cáncer se ha segmentado en hospitales, centros de diagnóstico, institutos oncológicos y laboratorios de investigación. El segmento de hospitales tuvo la mayor participación de mercado en 2019, mientras que se estima que el segmento de centros de diagnóstico registrará la CAGR más alta del mercado durante el período de pronóstico.
Estratégico Insights
Los lanzamientos y aprobaciones de productos son una estrategia comúnmente adoptada por las empresas en el mercado de detección del cáncer de mama para expandir su presencia en todo el mundo y satisfacer la creciente demanda ampliando sus carteras de productos. También adoptan la estrategia de expansión para ampliar la base de clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial. Por ejemplo, en junio de 2017, Siemens Healthineers recibió la aprobación de la Administración de Alimentos y Medicamentos (FDA) para un producto llamado syngo.via VB20, que probablemente se utilizará para imágenes moleculares (MI) de Siemens Healthineers; una nueva versión del software de visualización inteligente establecido por la compañía para imágenes multimodales.
Mercado de detección de cáncer de mama: ndash; Por tipo de producto
- Prueba de marcadores sanguíneos
- Prueba de imágenes
- Prueba genética
- Prueba de inmunohistoquímica
Mercado de detección del cáncer de mama - ndash; Por aplicación
- Centros de diagnóstico
- Hospitales
- Laboratorios de investigación
- Institutos oncológicos
Detección del cáncer de mama: prueba de detección del cáncer de mama. Por geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de Asia Pacífico
- Oriente Medio y África
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de Oriente Medio y África
- América del Sur
- Brasil
- Argentina
- Resto de América del Sur
Perfiles de empresas
- Compañía General Electric
- Siemens Healthineers AG
- Exact Sciences Corporation
- Koninklijke Philips NV
- Hologic, Inc.
- BD
- Myriad Genetics, Inc.
- Onccite Corporation
- Danaher
- POC Medical Sistemas
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The diagnosis of breast cancer is done through breast cancer screening methods such as mammography, magnetic resonance imaging (MRI), ultrasound, and others. Screening examinations are tests performed for early diagnosis of the disease. The foremost goal of screening is to detect disease at its earliest and most treatable stage.
The growth of the market is attributed to some key driving factors such as increasing number of breast cancer cases, growing geriatric population and rising adoption of technology for screening purpose. However, high cost of screening method and bassinet on global business due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.
The North American region holds the largest market for the breast cancer screening. The United States held the largest market for breast cancer screening mean market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer, growing developments for screening and imaging process by the companies and others.
The List of Companies - Breast Cancer Screening Market
- Koninklijke Philips N.V..
- HOLOGIC, INC.
- BD
- MYRIAD GENETICS, INC.
- SIEMENS HEALTHCARE GMBH
- Exact Sciences Corporation
- ONCOCYTE CORPORATION
- POC MEDICAL SYSTEMS
- Danaher
- GENERAL ELECTRIC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)